BLADDER TRANSITIONAL CELL CARCINOMA STAGE III

This adverse event was reported 39 times

BLADDER TRANSITIONAL CELL CARCINOMA STAGE III is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ALOGLIPTIN AND PIOGLITAZONE 1 0.0040
1 NATEGLINIDE 2 0.0015
2 BISACODYL 5MG 1 0.0011
3 ACETAMINOPHEN AND CODEINE PHOSPHATE 2 0.0011
4 ALFUZOSIN HYDROCHLORIDE 1 0.0004
5 REPAGLINIDE 2 0.0003
6 PIOGLITAZONE 10 0.0002
7 THALIDOMIDE 4 0.0001
8 INSULIN GLULISINE 1 0.0001
9 METFORMIN HCL 4 0.0001
See all drugs enriched for association with BLADDER TRANSITIONAL CELL CARCINOMA STAGE III